Table 1 Seroconversion and seroreversion rates for models based on AMA1, CelTOS and CSP
From: Anti-sporozoite antibodies as alternative markers for malaria transmission intensity estimation
Antigen | Month of survey | Number of subjects (N = 882) | Seroconversion rate (95% CI) | Seroreversion rate (95% CI) |
|---|---|---|---|---|
AMA1 | February | 294 | 0.144 (0.089, 0.235) | 0.131 (0.057, 0.302) |
May | 294 | 0.074 (0.051, 0.108) | 0.005 (0.000, 51.872) | |
August | 294 | 0.078 (0.051, 0.118) | 0.034 (0.005, 0.223) | |
§Total (AMA1) | 0.095 (0.070, 0.129) | 0.055 (0.022, 0.135) | ||
CelTOS | February | 294 | 0.026 (0.013, 0.054) | 0.057 (0.005, 0.609) |
May | 294 | 0.027 (0.012, 0.059) | 0.079 (0.010, 0.617) | |
August | 294 | 0.020 (0.015, 0.027) | 0.0000002 (0.00, 4718.9) | |
§Total (CelTOS) | 0.023 (0.013, 0.041) | 0.036 (0.002, 0.552) | ||
CSP | February | 294 | λ1 = 0.226 (0.073, 1.700) | 0.171 (0.093, 0.311) |
*LRT: P < 0.01 | λ2 = 0.022 (0.012, 0.040) | |||
May | 294 | 0.033 (0.014, 0.077) | 0.132 (0.029, 0.595) | |
August | 294 | 0.028 (0.014, 0.055) | 0.054 (0.006, 0.512) | |
§Total (CSP) | *LRT: P < 0.01 | λ1 = 0.319 (0.084, 1.219) | 0.278 (0.166, 0.464) | |
λ2 = 0.024 (0.013, 0.044) | ||||